TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each June 11, 1982
TCL Archive Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays June 1, 1979